Investors

Verndari is currently supported by a select group of two dozen “Angel Investors”.

Many Investors have held Senior Executive Positions in the Pharmaceutical Industry, Healthcare Industry and Banking.

Vaccine Vision

A broad family of room temperature stable vaccines self administered via a painless patch...

read more
Featured Article
Featured Team Member

Dr. Peter A. Barry
Director, Center for Comparative Medicine, University of California, Davis

Dr. Barry was Director of the California National Primate Research Center at Davis. His research is on mechanisms of cytomegalovirus (CMV) persistence and pathogenesis, as well as human CMV vaccine strategies as tested in non-human primate models.

read more